Clinical Trials Browser

Phase 1 × Adenocarcinoma × Lymphoid × Clear all

NCT01962532 2019-05-15

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma

Phase 1 Completed

Adenocarcinoma, Lymphoma, Neoplasms